Axel Bolte Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Axel Bolte.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Axel Bolte. Axel Bolte is a Director in PTC THERAPEUTICS, INC. ($PTCT) and a Director in Ophthotech Corp. ($OPHT) and a Director in Allena Pharmaceuticals, Inc. ($ALNA) and an Chief Executive Officer in Inozyme Pharma, Inc. ($INZY) and a See Remarks in Inozyme Pharma, Inc. ($INZY).
Address: PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD 07080 NJ
Companies in which Axel Bolte is an Insider
Allena Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Axel Bolte: Director
Holdings: 0 shares
Latest Transaction: Jun 12 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Inozyme Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Axel Bolte: Chief Executive Officer, See Remarks
Holdings: 0 shares
Latest Transaction: Mar 17 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Axel Bolte: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PTC THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Axel Bolte: Director
Holdings: 20,000 shares
Current Value: $269,200
Latest Transaction: Jun 27 2013
$PTCT Market Capitalization: $452.34M
$PTCT Previous Close: $13.46
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Axel Bolte
Sentiment: All, ALNA, INZY, OPHT, PTCT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 19.78 | 117,000 | 2,314,260 | 117,000 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 16.00 | 66,788 | 1,068,608 | 66,788 | |
| Jan 14 2021 | INZY | Inozyme Pharma, In ... | Bolte Axel | Chief Executive Off ... | Option Exercise | A | 2.77 | 159,187 | 440,948 | 159,187 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bolte Axel | See Remarks | Option Exercise | A | 16.00 | 287,706 | 4,603,296 | 287,706 | |
| Jul 24 2020 | INZY | Inozyme Pharma, In ... | Bolte Axel | See Remarks | Option Exercise | A | 16.00 | 287,706 | 4,603,296 | 287,706 | |
| Jun 11 2020 | OPHT | IVERIC bio, Inc. | Bolte Axel | Director | Option Exercise | A | 4.14 | 16,000 | 66,240 | 16,000 | |
| May 16 2019 | OPHT | IVERIC bio, Inc. | Bolte Axel | Director | Option Exercise | A | 1.39 | 16,000 | 22,240 | 16,000 |